FDA.reportPublic FDA data

NDC 73198-144

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC
73198-144
Product root
73198-144
Identity scope
Product
Primary current NDC product row
Not present

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
compounderpackage73198-14473198-144-30COMPOUNDEROutsourcing facility compounded drug report2023-12026-08-01

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCProductActive ingredientsReporting periodNormalization
OLYMPIA PHARMACY01767436873198-14473198-144-30.alpha.-Lipoic Acid25 mg/1 mL2023-1valid